Age-dependent shift in the de novo proteome accompanies pathogenesis in an Alzheimer’s disease mouse model

[1]  E. Nollen,et al.  Regulation of Age-Related Protein Toxicity , 2021, Frontiers in Cell and Developmental Biology.

[2]  S. Birman,et al.  Hedgehog Signaling Modulates Glial Proteostasis and Lifespan. , 2020, Cell reports.

[3]  Daniel B. McClatchy,et al.  A Temporal Quantitative Profiling of Newly Synthesized Proteins during Aβ Accumulation , 2020, bioRxiv.

[4]  Li Luo,et al.  Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice , 2019, Aging.

[5]  Gary D. Bader,et al.  Single-cell transcriptomic profiling of the aging mouse brain , 2019, Nature Neuroscience.

[6]  C. Holt,et al.  Local translation in neurons: visualization and function , 2019, Nature Structural & Molecular Biology.

[7]  L. Bodea,et al.  Decreased synthesis of ribosomal proteins in tauopathy revealed by non‐canonical amino acid labelling , 2019, EMBO Journal.

[8]  E. Klann,et al.  Altered steady state and activity-dependent de novo protein expression in fragile X syndrome , 2019, Nature Communications.

[9]  S. Carr,et al.  TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach* , 2019, Molecular & Cellular Proteomics.

[10]  C. Keene,et al.  Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer’s disease model mice , 2019, The Journal of clinical investigation.

[11]  A. Grimm,et al.  Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer’s disease , 2019, Cellular and Molecular Life Sciences.

[12]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[13]  C. Holt,et al.  On-Site Ribosome Remodeling by Locally Synthesized Ribosomal Proteins in Axons , 2018, bioRxiv.

[14]  Kathryn Goozee,et al.  Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies , 2018, Journal of Alzheimer's disease : JAD.

[15]  Mitesh Patel,et al.  ZCCHC17 is a master regulator of synaptic gene expression in Alzheimer's disease , 2018, Bioinform..

[16]  R. Swerdlow.  Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[17]  K. Fujii,et al.  Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide. , 2017, Molecular cell.

[18]  José Cristóbal Riquelme Santos,et al.  Machine learning techniques to discover genes with potential prognosis role in Alzheimer's disease using different biological sources , 2017, Inf. Fusion.

[19]  R. Nixon.  Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  J. Lucas,et al.  Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome , 2016, Brain pathology.

[21]  C. Vogel,et al.  BONLAC: A combinatorial proteomic technique to measure stimulus-induced translational profiles in brain slices , 2016, Neuropharmacology.

[22]  E. Klann,et al.  Mitochondrial Superoxide Contributes to Hippocampal Synaptic Dysfunction and Memory Deficits in Angelman Syndrome Model Mice , 2015, The Journal of Neuroscience.

[23]  A. Cuervo,et al.  Proteostasis and aging , 2015, Nature Network Boston.

[24]  U. Pati,et al.  CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase , 2015, Aging cell.

[25]  Yong Tae Kwon,et al.  Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.

[26]  E. Airoldi,et al.  Differential Stoichiometry among Core Ribosomal Proteins , 2014, bioRxiv.

[27]  L. Ji,et al.  Exercise-Induced Neuroprotection of Hippocampus in APP/PS1 Transgenic Mice via Upregulation of Mitochondrial 8-Oxoguanine DNA Glycosylase , 2014, Oxidative medicine and cellular longevity.

[28]  Guoan Zhang,et al.  In-Depth Quantitative Proteomic Analysis of de Novo Protein Synthesis Induced by Brain-Derived Neurotrophic Factor , 2014, Journal of proteome research.

[29]  Wei Huang,et al.  Translational control in synaptic plasticity and cognitive dysfunction. , 2014, Annual review of neuroscience.

[30]  M. Frosch,et al.  Tracking the earliest pathologic changes in Alzheimer disease , 2014, Neurology.

[31]  W. Gan,et al.  Antipsychotics Activate mTORC1-Dependent Translation to Enhance Neuronal Morphological Complexity , 2014, Science Signaling.

[32]  D. Munoz,et al.  TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. , 2013, Cell metabolism.

[33]  G. Hu,et al.  Aerobic Exercise Combined with Antioxidative Treatment does not Counteract Moderate‐ or Mid‐Stage Alzheimer‐Like Pathophysiology of APP/PS1 Mice , 2013, CNS neuroscience & therapeutics.

[34]  E. Klann,et al.  Genetic reduction of the α1 subunit of Na/K-ATPase corrects multiple hippocampal phenotypes in Angelman syndrome. , 2013, Cell reports.

[35]  J. DeFelipe,et al.  Synaptic Changes in the Dentate Gyrus of APP/PS1 Transgenic Mice Revealed by Electron Microscopy , 2013, Journal of neuropathology and experimental neurology.

[36]  F. Ebner,et al.  In vivo quantitative proteomics of somatosensory cortical synapses shows which protein levels are modulated by sensory deprivation , 2013, Proceedings of the National Academy of Sciences.

[37]  E. Klann,et al.  Suppression of eIF2 a kinases alleviates Alzheimer’s disease–related plasticity and memory deficits , 2013 .

[38]  Katrin Eichelbaum,et al.  Selective enrichment of newly synthesized proteins for quantitative secretome analysis , 2012, Nature Biotechnology.

[39]  Michael J. Sweredoski,et al.  Dopaminergic modulation of the hippocampal neuropil proteome identified by bioorthogonal noncanonical amino acid tagging (BONCAT) , 2012, Proteomics.

[40]  Heng Du,et al.  Synaptic mitochondrial pathology in Alzheimer's disease. , 2012, Antioxidants & redox signaling.

[41]  E. Klann,et al.  Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex , 2012, Neurobiology of Disease.

[42]  I. Willis,et al.  Eukaryotic Cells Producing Ribosomes Deficient in Rpl1 Are Hypersensitive to Defects in the Ubiquitin-Proteasome System , 2011, PloS one.

[43]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[44]  Jerry Yang,et al.  Inhibitors of Catalase-Amyloid Interactions Protect Cells from β-Amyloid-Induced Oxidative Stress and Toxicity* , 2010, The Journal of Biological Chemistry.

[45]  M. Jensen,et al.  Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis , 2010, Neurobiology of Aging.

[46]  C. Hölscher,et al.  Synaptic Plasticity in the Hippocampus of a APP/PS1 Mouse Model of Alzheimer's Disease Is Impaired in Old but Not Young Mice , 2010, PloS one.

[47]  E. Klann,et al.  Dysregulation of mTOR Signaling in Fragile X Syndrome , 2010, The Journal of Neuroscience.

[48]  W. Markesbery,et al.  Neuropathologic alterations in mild cognitive impairment: a review. , 2010, Journal of Alzheimer's disease : JAD.

[49]  M. Jendrach,et al.  Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice , 2009, Neurobiology of Aging.

[50]  O. Arancio,et al.  Reversal of long-term dendritic spine alterations in Alzheimer disease models , 2009, Proceedings of the National Academy of Sciences.

[51]  Sylvain Rheims,et al.  Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy , 2009, The Journal of Neuroscience.

[52]  N. Sonenberg,et al.  Translational Control of Long-Lasting Synaptic Plasticity and Memory , 2009, Neuron.

[53]  E. Klann,et al.  Making synaptic plasticity and memory last: mechanisms of translational regulation. , 2009, Genes & development.

[54]  Qingzhong Liu,et al.  Independent component analysis of Alzheimer's DNA microarray gene expression data , 2009, Molecular Neurodegeneration.

[55]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[56]  A. Gruart,et al.  Aged wild-type and APP, PS1, and APP+PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load , 2008, Neurobiology of Disease.

[57]  Costel C. Darie,et al.  Stable Isotopic Labeling by Amino Acids in Cultured Primary Neurons , 2008, Molecular & Cellular Proteomics.

[58]  J. Glennon,et al.  Age‐related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild‐type mice , 2008, Journal of neurochemistry.

[59]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[60]  P. Moreira,et al.  Alzheimer's disease: a lesson from mitochondrial dysfunction. , 2007, Antioxidants & redox signaling.

[61]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[62]  N. Harel,et al.  Subcutaneous Nogo Receptor Removes Brain Amyloid-β and Improves Spatial Memory in Alzheimer's Transgenic Mice , 2006, The Journal of Neuroscience.

[63]  Hartwig Wolburg,et al.  Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.

[64]  Daniela C Dieterich,et al.  Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Stavros J. Baloyannis,et al.  Mitochondrial alterations in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[66]  W. Markesbery,et al.  Ribosome Dysfunction Is an Early Event in Alzheimer's Disease , 2005, The Journal of Neuroscience.

[67]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[68]  Ottavio Arancio,et al.  Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease. , 2005, Current Alzheimer research.

[69]  B. Winblad,et al.  Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain , 2004, Neuroreport.

[70]  Ottavio Arancio,et al.  Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice , 2004, Annals of neurology.

[71]  Wei-Lun Chang,et al.  Molecular characterization of a novel nucleolar protein, pNO40. , 2003, Biochemical and biophysical research communications.

[72]  H. Braak,et al.  Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. , 2003, The American journal of pathology.

[73]  R. Chang,et al.  Phosphorylation of eukaryotic initiation factor-2&agr; (eIF2&agr;) is associated with neuronal degeneration in Alzheimer's disease , 2002, Neuroreport.

[74]  I. Ferrer.  Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt–Jakob's disease , 2002, Neuropathology and applied neurobiology.

[75]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[76]  Nick C Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[77]  N. Kenmochi,et al.  The human ribosomal protein genes: sequencing and comparative analysis of 73 genes. , 2002, Genome research.

[78]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[79]  W. Markesbery,et al.  Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.

[80]  A. Nunomura,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[81]  K. Blennow,et al.  Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study , 2000, Journal of Neural Transmission.

[82]  S. Ng,et al.  Aberrant GAP-43 gene expression in Alzheimer's disease. , 1995, The American journal of pathology.

[83]  Jinhe Li,et al.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.

[84]  B. Winblad,et al.  Alzheimer's disease-associated reduction of polysomal mRNA translation. , 1989, Brain research. Molecular brain research.

[85]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[86]  C. Marotta,et al.  Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. , 1984, Science.

[87]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .